Impact of biochemical failure on overall survival after radiation therapy for localized prostate cancer in the PSA era - International Journal of Radiation Oncology, Biology, Physics
Oncotarget: Melatonin increases overall survival of prostate cancer patients | Oncotarget
Overall survival of metastatic prostate cancer patients starting... | Download Scientific Diagram
TITAN trials demonstrates significantly Improved Overall Survival and Radiographic Progression-Free Survival for Apalutamide in Patients with Metastatic Castration-Sensitive Prostate Cancer - Onco Americas
Which Factors Predict Overall Survival in Patients With Metastatic Castration-Resistant Prostate Cancer Treated With Abiraterone Acetate Post-Docetaxel? - Clinical Genitourinary Cancer
Kaplan-Meier analysis of overall survival among prostate cancer... | Download Scientific Diagram
Association Between Second Progression-free Survival (PFS2) and Overall Survival in Metastatic Castration-resistant Prostate Cancer - European Urology
Overall survival of metastatic prostate cancer patients starting... | Download Scientific Diagram
Prognostic factors for overall survival in prostate cancer patients with different site-specific visceral metastases: A study of 1358 patients
Overall survival of black and white men with metastatic castration-resistant prostate cancer (mCRPC): a 20-year retrospective analysis in the largest healthcare trust in England | Prostate Cancer and Prostatic Diseases
Prognostic Factors for Survival in Noncastrate Metastatic Prostate Cancer: Validation of the Glass Model and Development of a Novel Simplified Prognostic Model - European Urology
Impact of DNA damage repair defects on response to radium-223 and overall survival in metastatic castration-resistant prostate cancer - European Journal of Cancer
Overall survival and prognostic factors prostate cancer in Kurdistan Province-Iran: a population-based study (2011-2018) | BMC Cancer | Full Text
A) Prostate cancer–specific survival and (B) overall survival... | Download Scientific Diagram
Survival with Olaparib in Metastatic Castration-Resistant Prostate Cancer | NEJM
Recent Advances in the Management of Metastatic Prostate Cancer | JCO Oncology Practice
Correlation of Prostate-specific Antigen Kinetics with Overall Survival and Radiological Progression-free Survival in Metastatic Castration-sensitive Prostate Cancer Treated with Abiraterone Acetate plus Prednisone or Placebos Added to Androgen ...
ASCO GU 2022: The Changing Landscape of Treatment and Survival for Men with Castration-Resistant Prostate Cancer in the Era of Novel Treatments
A) Progression-free survival and (B) overall survival in... | Download Scientific Diagram
Prostate-specific Antigen Decline After 4 Weeks of Treatment with Abiraterone Acetate and Overall Survival in Patients with Metastatic Castration-resistant Prostate Cancer - European Urology
PLOS ONE: Prostate-specific membrane antigen in circulating tumor cells is a new poor prognostic marker for castration-resistant prostate cancer
prostate cancer and hormones
